For Members, ASGCT Has More Programming, Research Funding, and Opportunities Than Ever

Join the largest CGT community - October 03, 2023

If you're not a member yet, join today to get the remainder of 2023 for free.

Whether you’re a thinking about becoming a member or you've supported the Society from the start, we want to remind you of a few reasons why you should join ASGCT or renew your membership for the next year.  

Contribute to a growing community. ASGCT is the largest association involved in genetic and cellular therapies and continues to grow every year. Our multidisciplinary group is now up to more than 6,000 members. That means when you renew, you’ll maintain access to our membership directory that comprises a unique mix of individuals in academia, industry, government, advocacy, and more. You can also collaborate with fellow members by joining a standing or scientific committee, volunteering to review posters or abstracts, or networking at one of our events

Advance your career and showcase your research. Want to sharpen your professional skills to move forward in your career? Take advantage of: 

Attend an event or watch one on demand. We have more events than we’ve ever had before. Our Annual Meeting remains the premier place to be for the latest scientific updates and the largest gathering of members at all stages of their careers—from students to Nobel laureates like Drew Weissman, MD, PhD, and Jennifer Doudna, PhD. Members can also: 

If you're ready to renew, the easiest way to do so is automatically. Last year we began offering an auto-renewal option so members can keep a cleaner email inbox while maintaining access to all the benefits above. Auto-renew to receive fewer messages from us so you can continue enjoying your membership with no interruption. 

Renew Your Membership

Not a member yet? Become one today to get the remainder of 2023 for FREE. 



Related Articles


Dr. Terence Flotte Calls for CGT Investment and Collaboration During Congressional Testimony

Read Dr. Flotte's testimony + watch the hearing - February 29, 2024

Mohamed Abou-el-Enein Appointed Editor of Molecular Therapy Methods and Clinical Development

Dr. Abou-el-Enein began five-year term Jan. 1. - January 04, 2024

Drew Weissman & Katalin Karikó to Co-Receive 2023 Nobel Prize for Discoveries in mRNA Technology

October 02, 2023

Congratulations to Awardees of the ASGCT & Pfizer Medical Education Grants!

August 15, 2023